Featured Articles
Latest Articles
- All sulfa drugs are not created equal
Misinformation about “sulfa allergy” can result in unnecessary avoidance of useful medications and the prescription of less effective alternatives.
- Sarcoidosis with diffuse purplish erythematous plaques on the hands
A 70-year-old woman presented in winter with a 1-month history of asymptomatic redness of the hands.
- Psychedelic-assisted therapy: An overview for the internist
The authors review the potential effects, risks, and therapeutic applications of the psychedelic drugs MDMA (Ecstasy) and psilocybin, with a focus on MDMA-assisted therapy for posttraumatic stress disorder and psilocybin-assisted therapy for depression.
- Coronary artery bypass grafting: Practice trends and projections
Future directions include expanding the use of multiarterial grafting, offering patients less-invasive approaches, and enhancing operative recovery.
- Can my patient with a ‘sulfa allergy’ receive celecoxib or other nonantimicrobial sulfonamides?
There is no cross-reactivity between antimicrobial and nonantimicrobial sulfonamides, and patients with a history of immunoglobulin E–mediated reaction to a sulfonamide antibiotic can receive nonantimicrobial sulfonamides.
- Cardiovascular disease in people living with HIV: Risk assessment and management
Because people living with HIV develop coronary artery disease much earlier than the general population, careful attention must be given to assessment and management of their cardiovascular risk.
Cleveland Clinic Journal of Medicine, published by Cleveland Clinic, provides busy clinicians with practical information to promote better patient care.